MAPT and Alzheimer disease: Evidence suggests microglial activation precedes regional tau and neurodegeneration in AD and, reflecting this, higher uptake of TSPO radiotracers such as [11C]PBR28 has been associated with higher Aβ and tau burden, as well as lower MMSE score [16].